ArticleThe World Allergy Organization journal2024
Type 2 asthma paediatric patients eligible for dupilumab: An Italian biomarker-based analysis.
Giorgio Piacentini et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it